Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|---|
| Revenue | 4.37bn | 3.28bn | 2.05bn |
| Cost of revenue | 167m | 166m | 138m |
| Research and development | 365m | 231m | 129m |
| Selling, general and administrative | 287m | 239m | 142m |
| Pre-tax income | 1.41bn | 891m | 205m |
| Income tax | 101m | 26m | 291,000 |
| Net income | 1.31bn | 866m | 203m |
| Earnings per share | 9.29 | 4.34 | −4.68 |
| Earnings per share, diluted | 4.57 | 3.19 | −4.68 |
| Weighted average shares | 216m | 100m | 71m |
| Weighted average shares, diluted | 286m | 271m | 71m |
| Metric | Aug 19, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|---|
| Cash and equivalents | — | 860m | 1.90bn | 863m | — |
| Short-term investments | — | 2.83bn | 336m | — | — |
| Receivables | — | 441m | 261m | — | — |
| Current assets | — | 4.46bn | 2.67bn | — | — |
| Property, plant and equipment | — | 14m | 5m | — | — |
| Total assets | — | 4.66bn | 2.78bn | — | — |
| Current liabilities | — | 1.14bn | 941m | — | — |
| Total liabilities | — | 1.31bn | 993m | — | — |
| Equity | — | 3.35bn | −1.63bn | −2.14bn | −1.88bn |
| Shares outstanding | — | — | 107m | — | — |
| Shares issued | — | — | 107m | — | — |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | 1.50bn | 1.21bn | 442m |
| Share-based compensation | 74m | 64m | 37m |
| Capital expenditure | 19m | 3m | 5m |
| Investing cash flow | −2.72bn | −158m | −45m |
| Financing cash flow | 197m | −9m | 18m |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)